Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06295744 · ClinicalTrials.gov registry record · NA

Outcomes and Cosmesis With Whole Breast Irradiation and Boost

A NA study of Early Stage Breast Cancer, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06295744 is a NA study of Early Stage Breast Cancer that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 50 participants, below the 412-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06295744, a NA study of Early Stage Breast Cancer, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

Conditions Studied

Interventions

  • RADIATION Radiation Therapy

Study Locations (1)

Wisconsin

  • UW Carbone Cancer Center - Madison

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-04-17
Est. Completion 2032-02
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06295744

The ClinicalTrials.gov registry entry for NCT06295744 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 412-participant average among 21 other Early Stage Breast Cancer trials with a reported enrollment target (88% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Early Stage Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Radiation Therapy is the first listed.

NCT06295744 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06295744 about?

NCT06295744 is a clinical study titled "Outcomes and Cosmesis With Whole Breast Irradiation and Boost". This study is being done to evaluate cosmetic, patient-reported outcome measures (PROMs), and toxicities for women undergoing ultra-short whole breast irradiation (WBI) therapy with simultaneous integrated boost (SIB). 50 participants will be on study for up to 60 months.

What is the current status of trial NCT06295744?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-17. Estimated completion is 2032-02.

What conditions does trial NCT06295744 study?

This clinical trial studies the following conditions: Early Stage Breast Cancer.

What interventions are being tested in trial NCT06295744?

The interventions under investigation include: Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT06295744?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06295744 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Early Stage Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.